3-Oxo-3,4-dihydroquinoxaline-6-carboxylic acid, 95+%, 250mg

2,4-Dimethoxybenzonitrile>99.0%(GC)25g

2-Chloro-4-methoxy-5-nitropyrimidine, 95.0%, 250mg

2,2'-Dipyridyl Disulfide [for Peptide Synthesis]>98.0%(GC)(T)25g

Chloro(methyl)(phenyl)(vinyl)silane>98.0%(GC)5g

VINYLBORONIC ACID DIBUTYL ESTER, 95%, 1g

(S)-1-Cbz-3-Boc-Aminopiperidine, 95%, 1g

2-Bromobenzylsulfonamide, 97.0%, 500mg

4-(6-FLUOROPYRIDIN-2-YL)PIPERIDINE-4-CARBONITRILE HCL, 95.0%, 1g

Lithium sulphate, min. 99%, anhydrous, 100 g, plastic packaging.

6-BROMO-1-ISOPROPYL-1H-INDAZOLE-4-CARBOXYLIC ACID, 95.0%, 25g

2-(4-(Hydroxymethyl)phenyl)ethanol, 95%, 1g

(4R)-(-)-5,5-Dimethyl-2-hydroxy-4-phenyl-1,3,2-dioxaphosphinane 2-oxide hydrate, 97%, 250mg